Status:
COMPLETED
Biosignals by Wearable Devices in Hypothyroidism
Lead Sponsor:
Seoul National University Bundang Hospital
Conditions:
Hypothyroidism
Eligibility:
All Genders
20-60 years
Brief Summary
This is a prospective observational cohort study. Monitoring continuous biosignals using wearable devices in thyroid cancer patients who are planned to withdraw their levothyroxine for radioactive iod...
Detailed Description
A prospective observational cohort study including two groups. Hypothyroid group: Patients with differentiated thyroid carcinoma underwent total thyroidectomy Patients who are planned to withdraw th...
Eligibility Criteria
Inclusion
- Patients with differentiated thyroid carcinoma underwent total thyroidectomy
- Patients who are planned to get radioactive iodine therapy
- Patients who are able to use wearable device and smartphones
Exclusion
- Patients who are not able to use wearable device and smartphones
- Patients who are maintaining drugs affecting heart rate
- Patients who have any other disease which can affect biosignals
Key Trial Info
Start Date :
June 14 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 15 2020
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT04332770
Start Date
June 14 2019
End Date
October 15 2020
Last Update
January 5 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Seoul National University Bundang Hospital
Seongnam-si, Gyeonggi-do, South Korea, 13620